9
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Experimental Colonic Inflammation and Ulceration: Permeation of a Water-Soluble Contrast Medium as a Measure of ‘Disease’ Activity

, , , , &
Pages 757-763 | Received 23 Dec 1991, Accepted 09 Apr 1992, Published online: 08 Jul 2009

References

  • Ainsworth M, Eriksen J, Rasmussen JW, SchaffalitzkydeMuck-Adell OB. Intestinal permeability of 51Cr-labelled ethylene-diaminetetraacetic acid in patients with Crohn's disease and their healthy relatives. Scand J Gastroenterol 1989; 24: 993–8
  • Hollander D. Crohn's disease-a permeability disorder of the tight junction?. Gut 1988; 29: 1621–4
  • Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI. Increased intestinal permeability in patients with Crohn's disease and their healthy relatives: a possible etiologic factor. Ann Intern Med 1986; 105: 883–5
  • Bjarnason I, Peters TJ. Intestinal permeability, non-steroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: an overview. Gut 1989; 22–28, (Festschrift)
  • Olaison G, Sjodahl R, Tagesson C. Abnormal intestinal permeability in Crohn's disease. A possible pathogenic factor [review]. Scand J Gastroenterol 1990; 25: 321–8
  • Ramage JK, Hunt RH, Perdue MH. Changes in intestinal permeability and epithelial differentiation during inflammation in the rat. Gut 1988; 29: 57–61
  • Menzies IS, Laker MF, Pounder R, et al. Abnormal intestinal permeability to sugars in villous atrophy. Lancet 1979; 2: 1107–9
  • Andre F, Andre C, Emery Y, Forichon J, Descos L, Miniare Y. Assessment of the lactulose-mannitol test in Crohn's disease. Gut 1988; 29: 511–5
  • Juby LD, Rothwell J, Axon ATR. Cellobiose\mannitol sugar test-a sensitive tubeless test for coeliac disease: results on 1010 unselected patients. Gut 1989; 30: 476–80
  • Chadwick VS, Phillips SF, Hofmann AF. Measurement of intestinal permeability using low molecular weight polyethyl-eneglycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology 1977; 73: 247–51
  • Maxton DG, Bjarnasson I, Reynolds AP, Catt SD, Peters TJ, Menzies IS. Lactulose, 51Cr-labelled ethylendiamine-tetra-acetate, 1-rhamnose and polyethyleneglycol 500 as probe markers for assessment in vivo of human intestinal permeability. ClinSci 1986; 71: 71–80
  • O'Morain CA, Abelov CA, Cheruu LR, Fleischner GM. Chromium 51-ethylene-diaminetetraacetate: a useful test in the assessment of inflammatory bowel disease. J Lab Clin Med 1986; 108: 430–5
  • Ma TY, Hollander D, Krugliak P, Katz K. PEG 400, a hy-drophilic molecular probe for measuring intestinal permeability. Gastroenterology 1990; 98: 39–46
  • Falth-Magnusson K, Jansson G, Stenhammar L, Sundqvist T, Magnusson KE. Intestinal permeability assessed with different-sized polyethylene glycols in children undergoing small-intestinal biopsy for suspected celiac disease. Scand J Gastroenterol 1989; 24: 40–6
  • Ukabam SO, Clamp JR, Cooper BT. Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon. Digestion 1983; 17: 70–4
  • Chadwick VS, Phillips SF, Hofmann AF. Measurement of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). Gastroenterology 1977; 73: 241–6
  • Nossen Jos, Andrew E, Aakhus T, Berg KJ, Jørgensen NP. Iodixanol. Tidsskr Nor Laegeforen 1991; 9: 1108–11
  • Stordahl A, Laerum F. Water soluble contrast media compared with barium in enteric follow-through. Urinary excretion and radiographic efficacy in rats with intestinal ischemia. Invest Radiol 1988; 23: 471–7
  • Stordahl A. Urinary excretion of iohexol administered enterally in rats with intestinal ischemia. A transmural and transperitoneal route of transport. Scand J Gastroenterol 1988; 23: 751–4
  • Solheim KE, Laerum F, Stordahl A, Aase S. Urinary excretion of iohexol after enteral administration in rats with radiation injury of the small intestine. Scand J Gastroenterol 1991; 26: 1097–106
  • Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989; 96: 795–803
  • Edelson J, Palace G. High performance liquid chromatograpic determination of iohexo) in plasma, urine and feces. J Chro-matogr 1983; 274: 428–33
  • Skinnemoen K, Fagervoll R, Jacobsen T. Determination of Iopentol and other non-ionic contrast agents in biologic fluids by HPLC. Acta Radiol Scand 1987; 23–5, Suppl 370
  • Bjarnason I, Peters TJ, Veal N. A persistent defect in intestinal permeability in coeliac disease demonstrated by a slCr-labelled EDTA absorption test. Lancet 1983; 2: 323–5
  • Bjarnason I, Williams P, Smethurst P, Peters TJ, Levi AJ. Effect of non-steroidal anti-inflammatory drugs and prostaglandines on the permeability of the human small intestine. Gut 1986; 27: 1292–7
  • Jenkins RT, Rooney PJ, Jones DB, Bienenstock J, Goodacre RL. Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal inflammatory drug therapy? Br. J Rheumatol 1987; 26: 103–7
  • Jackson PG, Lessof MH, Baker RWR, Ferret J, MacDonald DM. Intestinal permeability in patients with eczema and food allergy. Lancet 1981; 2: 1285–6
  • Olaison G. Intestinal permeability and phospholipase A2 activity in Crohn's disease [thesis]. Linköping University, Linköping 1988, no. 276
  • Aabakken L. 5lCr-erhylenediaminetetraacetic acid absorption test. Methodologic aspects. Scand J Gastroenterol 1989; 24: 351–8
  • Lærum F, Stordahl A, Solheim KE, Haugstvedt JR, Roald HE, Skinningsrud K. Intestinal follow-through examinations with Iohexol and Iopentol. Permeability alterations and efficacy in patients with small bowel obstruction. Invest Radiol 1991; 26: 177–88
  • Stordahl A. Urinary excretion of enteral Iohexol in rats with intestinal ischemia. The influence of size of ischemia area and duration of exposure to contrast medium. Scand J Gastroenterol 1988; 23: 983–90

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.